Health
Health News
GenScript Biotech and Ligand Pharmaceuticals Enter into Global OmniAb® Licensing Agreement
GenScript Biotech and Ligand Pharmaceuticals Enter into Global OmniAb® Licensing Agreement Enables GenScript to expand rapid, high-quality, fully human antibody...
Read moreSS&C Signs Multiple Clients to its FRTB Solution
SS&C Signs Multiple Clients to its FRTB Solution Nova Ljubljanska banka and SDC implement SS&C Algorithmics' Fundamental Review of the...
Read moreTherapeutic Solutions International Subsidiary Campbell Neurosciences Identifies T Regulatory Cells as a Mechanism of Stem Cell Suppression of Schizophrenia Pathology in an Animal Model
Therapeutic Solutions International Subsidiary Campbell Neurosciences Identifies T Regulatory Cells as a Mechanism of Stem Cell Suppression of Schizophrenia Pathology...
Read moreAbbVie to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference
AbbVie to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference PR Newswire NORTH CHICAGO, Ill., June 2, 2021...
Read moreFusion Pharmaceuticals Enters into Agreement to Build Radiopharmaceutical Manufacturing Facility
Fusion Pharmaceuticals Enters into Agreement to Build Radiopharmaceutical Manufacturing Facility PR Newswire HAMILTON, ON and BOSTON, June 2, 2021 HAMILTON,...
Read moreKroger Health Partners with Trae Young and Turner Sports to Help Drive COVID-19 Vaccinations in Atlanta
Kroger Health Partners with Trae Young and Turner Sports to Help Drive COVID-19 Vaccinations in Atlanta Kroger pharmacies and clinics...
Read moreKindred Biosciences Announces Positive Results from Pivotal Efficacy Study of Parvovirus Monoclonal Antibody for the Prevention of Deaths in Dogs Infected by Parvovirus
Kindred Biosciences Announces Positive Results from Pivotal Efficacy Study of Parvovirus Monoclonal Antibody for the Prevention of Deaths in Dogs...
Read moreNeuroOne Introduces Advisory Board for Ablation Electrode Technology that Records and Ablates Brain Tissue Linked to Seizure Activity
NeuroOne Introduces Advisory Board for Ablation Electrode Technology that Records and Ablates Brain Tissue Linked to Seizure Activity PR Newswire...
Read moreHealth Canada Approves OPDIVO® (nivolumab) plus YERVOY® (ipilimumab) as the First and Only Immunotherapy Treatment for Previously Untreated Unresectable Malignant Pleural Mesothelioma
Health Canada Approves OPDIVO® (nivolumab) plus YERVOY® (ipilimumab) as the First and Only Immunotherapy Treatment for Previously Untreated Unresectable Malignant...
Read moreSanté Canada approuve OPDIVO(MD) (nivolumab) plus YERVOY(MD) (ipilimumab) comme premier et unique traitement d’immunothérapie de première intention du mésothéliome pleural malin non résécable
Santé Canada approuve OPDIVO(MD) (nivolumab) plus YERVOY(MD) (ipilimumab) comme premier et unique traitement d'immunothérapie de première intention du mésothéliome pleural...
Read more